Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31031254 | 0.88 | — | — | |
| SCHEMBL31031248 | 0.88 | — | — | |
| SCHEMBL31031235 | 0.83 | KDM4E (0.33) | ALDH1A1 | |
| SCHEMBL31031236 | 0.81 | — | — | |
| SCHEMBL31031218 | 0.79 | SUV39H2 (0.34) | NPC1ALDH1A1TP53MAPTALOX15 | |
| SCHEMBL31031228 | 0.79 | ALDH1A1 (0.32) | NPC1ALDH1A1TP53MAPTALOX15 | |
| SCHEMBL31031257 | 0.69 | ALDH1A1 (0.41) | NPC1ALDH1A1TP53MAPTALOX15 | |
| SCHEMBL29183366 | 0.69 | RXRA (0.34) | — | |
| SCHEMBL31406379 | 0.68 | HTT (0.32) | — | |
| SCHEMBL19714775 | 0.67 | ALDH1A1 (0.45) | NPC1ALDH1A1TP53MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658651-A1 | NOVEL COMPOUNDS FOR TAU IMAGING | Eli Lilly and Company (US) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024163546-A1 | NOVEL COMPOUNDS FOR TAU IMAGING | ELI LILLY AND COMPANY (US) | 2024-08-08 | — | — | WO | disclosed |